Meet the Team
Mr. Sunil has received a Master degree in Microelectronics from Indian Institute of Technology (IIT) Bombay and Bachelor degree in Instrumentation and Control Engineering from Gujarat University. He has more than 10 years of circuit design experience in industry leading companies, Qualcore Login Pvt. Ltd. (Hyderabad, India) Intel Technology India Pvt. Ltd. (Bangalore, India) and Samsung Electronics (Suwon, South Korea).
Mr. Naman is also Co-Founder and CEO of ListenIn, a media-tech company. Prior to venturing out Mr. Naman brings a blend of experience from engineering and management functions. Mr. Naman has over 11 years of experience, including 2 years in setting up and scaling entrepreneurial ventures, 3.5 years with Product Management & Corporate Strategy Group at HP (Bangalore, India) and 5.5 years in Software development and Integrated Circuit design at Qualcore Logic Pvt. Ltd. (Hyderabad, India) and National Semiconductor (Bangalore, India). He holds an engineering degree and an MBA from S. P. Jain Institute of Management & Research, Mumbai specializing in Marketing & technology management.
Speciality Interests: Paediatric
Experience: Passed M.B.B.S. from M.S. University Vadodara in 2001 and completed D.C.H. (Diploma In Child Health) in 2004 from same university. He is working at Kalrav Children Hospital, Kalol-Gandhinagar as full-time pediatrician since last eleven years. In 2015, he has inaugurated Vishwa Neonatal And Children Hospital in Gandhinagar. He is the initial investor in the company.
Dipak ParmarChief Operating Officer
Mr. Dipak Parmar is gold medalist in MBA from B.K. School of Business Management, Gujarat University, Ahmedabad. He has also Civil Engineering bachelor degree. Mr. Parmar backed up by 25 years of rich experience, will be responsible for overall Corporate Planning, MIS, Systems, Cost analysis, Project Financing, Fund raising and providing support for all technical aspects to various divisions. Apart from this, he also shoulders liaison work with all government departments and regulatory agencies since his major part of his career dealt to build pharmaceutical industry infrastructure.